Systemic therapy with the tyrosine kinase inhibitor lenvatinib in six patients with distantly metastatic malignant melanoma

被引：0
|
作者：
Klumpp, A. [1 ]
Stege, H. [1 ]
Lang, B. [1 ]
Grabbe, S. [1 ]
机构：
[1] Univ Mainz Mainz, Hautklin, Mainz, Germany
来源：
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT | 2023年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
eP076
引用
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [1] A Regional Review of Outcomes of Systemic Therapy in Patients With Metastatic Malignant Melanoma
    Khan, K.
    Goody, R. B.
    Hameed, H.
    Coyle, V.
    McAleer, J. J. A.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S658 - S658
  • [2] Salvage lenvatinib/everolimus combination therapy after immune checkpoint inhibitor and VEGFR tyrosine kinase inhibitor for metastatic renal cell carcinoma
    Kwok, Christopher
    Khorasanchi, Adam
    Psutka, Sarah P.
    Hinkley, Megan
    Dason, Shawn
    Sundi, Debasish
    Yang, Yuanquan
    Yang, Yajing
    Verschraegen, Claire
    Gross, Evan E.
    Orcutt, Delaney
    Yin, Ming
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [3] Tyrosine Kinase Inhibitor Therapy for Systemic Sclerosis: Quo Vadis?
    Mendoza, Fabian A.
    Jimenez, Sergio A.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (11): : 3199 - 3203
  • [4] Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor Responses in KIT-Mutant Metastatic Melanoma
    McKean, Meredith
    Oba, Junna
    Ma, Junsheng
    Roth, Katherine G.
    Wang, Wei-Lien
    Macedo, Mariana P.
    Carapeto, Fernando C. L.
    Haydu, Lauren E.
    Siroy, Alan E.
    Vo, Phuong
    Hong, David S.
    Eterovic, Agda K.
    Patel, Keyur Pravinchandra
    Bassett, Roland L., Jr.
    Grimm, Elizabeth A.
    Lazar, Alexander J.
    Woodman, Scott E.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (03) : 728 - 731
  • [5] Analysis of the dynamics in the immune system of patients with metastatic melanoma in response to systemic therapy with metastatic melanoma in response to systemic therapy
    Leontovich, A. A.
    Dronca, R. S.
    Nevala, W. K.
    Suman, V.
    Kottschade, L. A.
    Ashdown, M. L.
    Kaur, J. S.
    Croghan, G.
    Markovic, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Systemic treatment of metastatic malignant melanoma
    Benhammouda, A
    Antoine, EC
    Daou, W
    Mortier, N
    Auclerc, G
    Nizri, D
    Soubrane, C
    Bassot, V
    Weil, M
    Khayat, D
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1312 - 1312
  • [7] Systemic Treatments with Tyrosine Kinase Inhibitor and Platinum-Based Chemotherapy in Patients with Unresectable or Metastatic Hepatocholangiocarcinoma
    Gigante, Elia
    Hobeika, Christian
    Le Bail, Brigitte
    Paradis, Valerie
    Tougeron, David
    Lequoy, Marie
    Bouattour, Mohamed
    Blanc, Jean-Frederic
    Ganne-Carrie, Nathalie
    Tran, Henri
    Hollande, Clemence
    Allaire, Manon
    Amaddeo, Giuliana
    Regnault, Helene
    Vigneron, Paul
    Ronot, Maxime
    Elkrief, Laure
    Verset, Gontran
    Trepo, Eric
    Zaanan, Aziz
    Ziol, Marianne
    Ningarhari, Massih
    Calderaro, Julien
    Edeline, Julien
    Nault, Jean-Charles
    LIVER CANCER, 2022, 11 (05) : 460 - 473
  • [8] Management of metastatic malignant Melanoma with a Secondary Malignancy under Systemic Therapy
    Vogiatzis, R.
    Lutze, S.
    Arnold, A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2019, 17 : 77 - 77
  • [9] Challenges Associated with Tyrosine Kinase Inhibitor Therapy for Metastatic Thyroid Cancer
    Cabanillas, Maria E.
    Hu, Mimi I.
    Durand, Jean-Bernard
    Busaidy, Naifa L.
    JOURNAL OF THYROID RESEARCH, 2011, 2011
  • [10] Cutaneous Adverse Effects of BRAF Inhibitor Therapy in Metastatic Malignant Melanoma
    Vanneste, L.
    Wolter, P.
    Garmyn, M.
    Stas, M.
    van den Oord, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 51 - 51
12345